1-[(3,4-DICHLOROPHENYL)MEHYL]-4(ETHYLOXY)-2,1,3-BENZOTHIADIAZINE-2,2-DIOXIDE
Compound with spectra: 1 NMR
![1-[(3,4-DICHLOROPHENYL)MEHYL]-4(ETHYLOXY)-2,1,3-BENZOTHIADIAZINE-2,2-DIOXIDE](/api/compound/9uwg08sf0TM.png?ph=true&h=300&w=458 "1-[(3,4-DICHLOROPHENYL)MEHYL]-4(ETHYLOXY)-2,1,3-BENZOTHIADIAZINE-2,2-DIOXIDE")
| SpectraBase Compound ID | 9uwg08sf0TM |
|---|---|
| InChI | InChI=1S/C16H14Cl2N2O3S/c1-2-23-16-12-5-3-4-6-15(12)20(24(21,22)19-16)10-11-7-8-13(17)14(18)9-11/h3-9H,2,10H2,1H3 |
| InChIKey | YYLWRTKPMHMQKX-UHFFFAOYSA-N |
| Mol Weight | 385.27 g/mol |
| Molecular Formula | C16H14Cl2N2O3S |
| Exact Mass | 384.010219 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
1-[(3,4-DICHLOROPHENYL)MEHYL]-4-(ISOPROPYLOXY)-2,1,3-BENZOTHIADIAZINE-2,2-DIOXIDE
1-(4-Biphenylylmethyl)-4-(4-biphenylylmethoxy)-2,1,3-benzothiadiazine 2,2-dioxide
Anthranilic acid, N-(p-tolylsulfonyl)-N-veratryl-, methyl ester
1-[(4-CHLOROPHENYL)METHYL]-3-ETHYL-2,1,3-BENZOTHIADIAZIN-4-ONE-2,2-DIOXIDE
7-chloro-1-(2-chloro-6-fluorobenzyl)-1H-2,1-benzothiazin-4(3H)-one, 2,2-dioxide
N-(4-methylbenzyl)-4-[(1-(4-methylbenzyl)-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)methyl]benzamide
4-(1-(4-chlorobenzyl)-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)-N-[2-(4-methylphenyl)ethyl]butanamide
3-(p-METHOXYBENZYL)-1-VERATRYL-2(1H)-QUINOXALINONE
5-(1-(4-chlorobenzyl)-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)-N-(4-methoxyphenyl)pentanamide
2-{[p-(2-chloro-6-fluorostyry)benzyl]thio}-3-(p-fluorophenyl)-4(3H)-quinazolinone
| Title | Journal or Book | Year |
|---|---|---|
| Benzothiadiazine dioxides (BTD) derivatives as non-nucleoside human cytomegalovirus (HCMV) inhibitors. study of structural requirements for biological activity☆ | Bioorganic & Medicinal Chemistry | 2003 |